Rare cells with extreme aneuploidy, resembling cancer genomes, were also identified, including mutations affecting tumor protein p53 (TP53) and BRCA1/BRCA2. These aneuploid cells were more common ...

In women with BRCA1 mutations, hormonal contraceptives were associated with a significantly higher risk for breast cancer in a dose-response relationship, researchers reported in an observational ...